Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Doria

Showing results (1-10 of 493) with videos related to

Pageof 50
Sort By:
The Journal of Rheumatology|November 7, 2009
Atherosclerosis and lupus: what we know and what we should knowAndrea Doria
Clinical and Experimental Rheumatology|August 4, 2019
Monotherapy is a relevant option in rheumatoid arthritis treatment: a literature reviewAndrea Doria, Daniela Zavaglia
Current Opinion in Rheumatology|September 21, 2018
New insights in myositis-specific autoantibodiesAnna Ghirardello, Andrea Doria
Annals of the Rheumatic Diseases|January 19, 2018
Response to: 'Remission or low disease activity as a target in systemic lupus erythematosus' by Ugarte-Gil <i>et al</i>Margherita Zen, Andrea Doria
Nature Clinical Practice. Rheumatology|September 10, 2008
Primary prevention of systemic lupus erythematosusAndrea Doria, Chiara Briani
Autoimmunity Reviews|August 26, 2023
Controversies in in rheumatology and autoimmunity: Is CORA meeting a good educational tool to increase the scientific knowledge?Mariangela Salvato, Andrea Doria
Rheumatology (Oxford, England)|December 6, 2020
Comment on: Prevalence, outcome and management of patients with SLE and secondary antiphospholipid antibody syndrome after aPL seroconversion: replyMargherita Zen, Andrea Doria
Autoimmunity|January 8, 2008
Organ specific-autoantibodies: their role as markers and predictors of diseasePiercarlo Sarzi-Puttini, Andrea Doria
Annals of the Rheumatic Diseases|November 22, 2015
Targeting BAFF/BLyS in lupus: is the glass half-full or half-empty?Frédéric A Houssiau, Andrea Doria
The New England Journal of Medicine|April 10, 2004
Premature coronary disease in systemic lupusAndrea Doria, Yehuda Shoenfeld, Paolo Pauletto
Pageof 50

Showing results (1-10 of 493) with videos related to

Sort By:
Pageof 50
The Journal of Rheumatology|November 7, 2009
Atherosclerosis and lupus: what we know and what we should knowAndrea Doria
Clinical and Experimental Rheumatology|August 4, 2019
Monotherapy is a relevant option in rheumatoid arthritis treatment: a literature reviewAndrea Doria, Daniela Zavaglia
Current Opinion in Rheumatology|September 21, 2018
New insights in myositis-specific autoantibodiesAnna Ghirardello, Andrea Doria
Annals of the Rheumatic Diseases|January 19, 2018
Response to: 'Remission or low disease activity as a target in systemic lupus erythematosus' by Ugarte-Gil <i>et al</i>Margherita Zen, Andrea Doria
Nature Clinical Practice. Rheumatology|September 10, 2008
Primary prevention of systemic lupus erythematosusAndrea Doria, Chiara Briani
Autoimmunity Reviews|August 26, 2023
Controversies in in rheumatology and autoimmunity: Is CORA meeting a good educational tool to increase the scientific knowledge?Mariangela Salvato, Andrea Doria
Rheumatology (Oxford, England)|December 6, 2020
Comment on: Prevalence, outcome and management of patients with SLE and secondary antiphospholipid antibody syndrome after aPL seroconversion: replyMargherita Zen, Andrea Doria
Autoimmunity|January 8, 2008
Organ specific-autoantibodies: their role as markers and predictors of diseasePiercarlo Sarzi-Puttini, Andrea Doria
Annals of the Rheumatic Diseases|November 22, 2015
Targeting BAFF/BLyS in lupus: is the glass half-full or half-empty?Frédéric A Houssiau, Andrea Doria
The New England Journal of Medicine|April 10, 2004
Premature coronary disease in systemic lupusAndrea Doria, Yehuda Shoenfeld, Paolo Pauletto
Pageof 50